T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.58B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Morgan Stanley
MS
|
+$1.15B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 5 |
Apple
AAPL
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$2.82B |
| 3 |
GE Aerospace
GE
|
+$1.93B |
| 4 |
Goldman Sachs
GS
|
+$1.88B |
| 5 |
ServiceNow
NOW
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.25% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.32% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
PMV Pharmaceuticals
PMVP
$65.1M
| $113K | ﹤0.01% |
23,617
+5,278
| +29% | +$37.1K |
|
|
BRY
2652
DELISTED
Berry Corp
BRY
| $112K | ﹤0.01% |
14,145
-3,441
| -20% | -$29.8K |
|
2653
CareCloud
CCLD
$104M
| $112K | ﹤0.01% |
33,200
+300
| +0.9% | +$1.05K |
|
2654
SES AI
SES
$227M
| $112K | ﹤0.01% |
+37,900
| New | +$119K |
|
2655
Clarus
CLAR
$145M
| $111K | ﹤0.01% |
11,686
+736
| +7% | +$6.92K |
|
2656
Workhorse Group
WKHS
$33.1M
| $111K | ﹤0.01% |
28
+12
| +75% | +$66.2K |
|
|
ME
2657
DELISTED
23andMe Holding Co
ME
| $110K | ﹤0.01% |
2,402
-628
| -21% | -$30.3K |
|
|
BLUE
2658
DELISTED
bluebird bio
BLUE
| $109K | ﹤0.01% |
1,704
+247
| +17% | +$28.2K |
|
|
WOW
2659
DELISTED
WideOpenWest
WOW
| $109K | ﹤0.01% |
+10,176
| New | +$110K |
|
|
ENZ
2660
DELISTED
Enzo Biochem, Inc.
ENZ
| $109K | ﹤0.01% |
44,800
| – | – |
|
|
YELL
2661
DELISTED
Yellow Corporation Common Stock
YELL
| $109K | ﹤0.01% |
53,255
+8,012
| +18% | +$21.4K |
|
2662
Phathom Pharmaceuticals
PHAT
$743M
| $108K | ﹤0.01% |
15,068
+118
| +0.8% | +$1.04K |
|
2663
RPC Inc
RES
$1.39B
| $108K | ﹤0.01% |
13,946
+892
| +7% | +$7.93K |
|
2664
Ring Energy
REI
$349M
| $107K | ﹤0.01% |
55,968
+391
| +0.7% | +$843 |
|
2665
Repay Holdings
RPAY
$317M
| $107K | ﹤0.01% |
16,189
+841
| +5% | +$6.92K |
|
|
CHMI
2666
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $106K | ﹤0.01% |
19,062
-2,114
| -10% | -$13.4K |
|
|
XRN
2667
Chiron Real Estate Inc
XRN
$484M
| $106K | ﹤0.01% |
2,312
+222
| +11% | +$11.2K |
|
2668
Organogenesis Holdings
ORGO
$226M
| $106K | ﹤0.01% |
49,366
+1,891
| +4% | +$4.67K |
|
|
SUNW
2669
DELISTED
Sunworks, Inc.
SUNW
| $106K | ﹤0.01% |
73,400
| – | – |
|
|
MCW
2670
DELISTED
Mister Car Wash
MCW
| $105K | ﹤0.01% |
12,161
+899
| +8% | +$8.43K |
|
|
ASTR
2671
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $105K | ﹤0.01% |
16,462
| – | – |
|
2672
Fulcrum Therapeutics
FULC
$283M
| $104K | ﹤0.01% |
36,461
-114,048
| -76% | -$1.02M |
|
2673
Inovio Pharmaceuticals
INO
$93M
| $104K | ﹤0.01% |
10,514
+2,547
| +32% | +$43.4K |
|
2674
Omeros
OMER
$1.26B
| $104K | ﹤0.01% |
22,200
-8,400
| -27% | -$30.3K |
|
|
KLRS
2675
Kalaris Therapeutics
KLRS
$92.4M
| $103K | ﹤0.01% |
1,136
-565
| -33% | -$72K |
|
Similar funds
T. Rowe Price Associates's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Associates held 3,020 positions worth $668B, up 7.5% from $622B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2023 filing shows 65 new, 1,711 increased, 924 reduced and 98 closed positions. Its largest new stake was Suncor Energy: 6,437,236 shares worth $200M. The largest sale was Alphabet (Google) Class C, an estimated $2.94B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2023 buy was Suncor Energy: 6,437,236 shares worth $200M.
- T. Rowe Price Associates added most to Tesla in Q1 2023, an estimated $1.58B increase.
- T. Rowe Price Associates's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $2.94B.
- T. Rowe Price Associates fully exited Signature Bank in Q1 2023, selling an estimated $360M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $668B portfolio in Q1 2023.
- T. Rowe Price Associates opened 65 new positions and closed 98 in Q1 2023.
- T. Rowe Price Associates's portfolio value rose 7.5% quarter-over-quarter to $668B.
Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.